Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Engineers Gate Manager LP closes position in PCRX / Pacira BioSciences, Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 0 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 56,498 shares of Pacira BioSciences, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 0 -100.00 0
2026-02-17 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 56,498 8,688 18.17 1,462 18.67 0.0173
2025-11-14 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 47,810 -32,151 -40.21 1,232 -35.53 0.0141
2025-08-14 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 79,961 35,780 80.99 1,911 74.20 0.0238
2025-05-15 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 44,181 -45,168 -50.55 1,098 -34.82 0.0185
2025-02-14 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 89,349 75,804 559.65 1,683 729.06 0.0293
2024-11-14 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 13,545 1,472 12.19 204 -41.16 0.0040
2024-08-14 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 12,073 -7,316 -37.73 345 -39.05 0.0078
2024-05-15 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 19,389 19,389 567 0.0149
2024-02-14 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 0 -9,294 -100.00 0 -100.00
2023-11-14 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 9,294 9,294 285 0.0105
2023-08-14 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 0 -16,693 -100.00 0 -100.00
2023-05-15 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 16,693 -35,406 -67.96 681 -66.14 0.0285
2023-02-14 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 52,099 52,099 2,012 0.1208
2021-11-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 0 -17,010 -100.00 0 -100.00
2021-08-16 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 17,010 750 4.61 1,032 -9.47 0.0664
2021-05-17 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 16,260 11,819 266.13 1,140 328.57 0.0565
2021-02-16 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 4,441 180 4.22 266 3.91 0.0115
2020-11-16 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 4,261 4,261 256 0.0120
2020-08-17 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 0 -45,266 -100.00 0 -100.00
2020-05-15 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 45,266 -21,699 -32.40 1,518 -49.97 0.1093
2020-02-14 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 66,965 66,965 3,034 0.1334
2019-11-14 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 0 -76,881 -100.00 0 -100.00
2019-08-14 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 76,881 -10,248 -11.76 3,344 0.84 0.1846
2019-05-15 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 87,129 24,711 39.59 3,316 23.50 0.2008
2019-02-14 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 62,418 -9,335 -13.01 2,685 -23.87 0.2149
2018-11-01 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 71,753 10,734 17.59 3,527 80.32 0.2710
2018-08-03 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 61,019 61,019 1,956 0.1524
2017-08-10 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 0 -12,496 -100.00 0 -100.00
2017-05-05 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 12,496 12,496 570 0.0566
2016-05-09 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -13,094 -100.00 0 -100.00
2016-02-05 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 13,094 13,094 1,005 0.0679
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.